Exchange: OTC·Updated 11:19 AM EDT

VRPX Virpax Pharmaceuticals Inc

$0.0001
$0.0001
(50.00%)
Today
Mkt Cap$124.00
Vol1,108.00

About VRPX

Virpax Pharmaceuticals, Inc. is a preclinical stage biopharmaceutical company, which engages in the development of branded, non-addictive pain management products. Its products include metered-dose spray, liposomal gel encapsulates, and intranasal spray. The company was founded by Anthony P. Mack and Jeffrey A. Gudin in 2016 and and is headquartered in Berwyn, PA.
45

Neutral Sentiment

How do you feel about VRPX?

Advertisement|Remove ads.